The rumored ‘Apple Glass’ might be adaptive in low-light environments.
In this week’s featured patent applications, we cover the latest from Apple, Intel, IBM, Boston Scientific, Medtronic, Roche, Novartis, and Merck.
Apple Pursues a Patent for a Head-Mounted Display with Low Light Operation
U.S. patent application, US20200341563, discloses a head-mounted display with infrared and ultrasonic sensors for sensing the environment and a controller to provide graphical content concurrent with the sensed environment. A top view of a head-mounted display unit on a head (H) of a user is illustrated below.
Intel Files a Patent Application for Techniques to Provide Accident Avoidance Information to Passengers of Autonomous Vehicles
U.S. patent application, US20200339157, describes an apparatus having a safety analyzer to determine whether a vehicle is in a safe or dangerous situation at different time periods, and a user interface to graphically present the vehicle’s situation at those time periods. The illustration below depicts generated user interfaces.
IBM Seeks a Patent for Automatic Summarization and Visualization of Multi-Platform Communications
U.S. patent application, US20200344279, discloses a method for analyzing the content of group communications between users across multiple platforms, such as instant messaging, email, video-conferencing, etc., and generating a report that indicates the content of the group communications. The figures below illustrate a system displaying an onboarding user report and a managing user report for the user.
Boston Scientific Files a Patent Application for a Lithotripsy Medical User Interface
U.S. patent application, US20200337529, relates to a medical system for use in lithotripsy procedures having a user interface that displays images captured in a lumen of a kidney, bladder, or ureter and a processor that analyzes the image to detect the presence of an object within the image, and estimates and displays the size of the object in the interface. The figure below shows the described user interface.
Medtronic Pursues Patents for Coated Endovascular Prostheses and a Modular Lighted Surgical Retractor
U.S. patent application, US20200338239, discloses an endovascular prosthesis having a hydrogel associated outer surface, which swells upon implantation within a blood vessel to mediate endovascular procedure complications and/or to aid in sealing. The conceptual figures below illustrate the above-described prosthesis.
Another application, US20200338267, discloses methods and systems having a processor for modifying therapy parameter values (a therapy program) for an electrical stimulation therapy based on an algorithmic model. The figure below illustrates an exemplary GUI for a user to generate an algorithmic model of the stimulation field produced by a selected therapy program as described above.
Roche Pursues a Patent for Modified Bacterial Luciferases
U.S. patent application, US20200339964, discusses bacterial luciferase enzymes with several amino acid substitutions in their sequence, which displays increased enzymatic activity as compared to wild-type or unmodified luciferases.
Novartis Files a Patent for PD-1 Antibody Molecules
U.S. patent application, US20200339689, discusses a method for the treatment of infectious diseases through the parenteral administration of anti Programmed Death-1 (PD-1) antibody molecules in combination with an agonist.
Merck Seeks a Patent for Effect Pigments Used in Inks and Cosmetics
U.S. patent application, US20200339820, discloses pearlescent pigments and metal-effect pigments based on flake-form substrates, which are coated with high-refractive-index layers to use in paints, coatings, printing inks, plastics, and cosmetic formulations.